An Android app for GMP professionals; World Courier drives AmerisourceBergen to emerging markets;

> Indian drugmaker Aurobindo Pharma, which has had some of its drugs banned from the U.S. since late 2010, says it expects the FDA to review its plant by September in anticipation of having the import ban lifted. Story

> The $58 million acquisition of CMO Alliance Medical Products will allow the Switzerland-based Siegfried Holding entrance into sterile filling services. Item

> The European Medicines Agency will implement in November a new policy for handling notifications from other regulators around the world about drugmakers failing GMPs. Story

> AmerisourceBergen ($ABC) CFO Tim Guttman says the company will use World Courier, which it bought last month for $520 million, to drive its emerging markets growth. Story

Sigma-Aldrich by July expects to have completed the move of its global chiral chromatography screening and small scale purification operations from Bellefonte, PA, to Cambridge, U.K. Release

And Finally... Ajay Pazhayattil, a pharmaceutical quality expert, has created a free Android app called eGMP, which organizes GMP requirements from around the world on any Android device. Item

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.